Ana Beloqui
Université Catholique de Louvain
H-index: 26
Europe-Belgium
Top articles of Ana Beloqui
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Drug Delivery and Translational Research
2024/4/13
Ana Beloqui
H-Index: 17
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention
Diabetologia
2024/2
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment
Bioactive materials
2024/2/1
“Green” synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokinetics
International journal of pharmaceutics
2024/1/25
Cheng Chen
H-Index: 1
Ana Beloqui
H-Index: 17
JCR EBM SI.
Journal of Controlled Release: Official Journal of the Controlled Release Society
2023/12/1
Nonalcoholic fatty liver disease: current therapies and future perspectives in drug delivery
2023/11/1
Ana Beloqui
H-Index: 17
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
2023/10/26
Poly-ɛ-caprolactone nanocapsules loaded with copaiba essential oil reduce inflammation and pain in mice
International Journal of Pharmaceutics
2023/7/25
Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease
Journal of Controlled Release
2023/4/1
Matthias Van Hul
H-Index: 20
Ana Beloqui
H-Index: 17
“Green”-synthesized zinc oxide nanoparticles and plant extracts: A comparison between synthesis processes and antihyperglycemic activity
International journal of pharmaceutics
2023/3/25
Ana Beloqui
H-Index: 17
An overview of herbal-based antidiabetic drug delivery systems: Focus on lipid-and inorganic-based nanoformulations
2022/10/8
Ana Beloqui
H-Index: 17
Barriers to the intestinal absorption of four insulin-loaded arginine-rich nanoparticles in human and rat
ACS nano
2022/8/23
Surface modification of lipid-based nanoparticles
2022/4/21
Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation
European Journal of Pharmaceutics and Biopharmaceutics
2022/3/1
Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease
Acta biomaterialia
2022/3/1
Lipid nanocapsules charged with incretin mimetics
2022/11/3
Quality-by-design-based development of a voxelotor self-nanoemulsifying drug-delivery system with improved biopharmaceutical attributes
Pharmaceutics
2021/9/2
Giulio G Muccioli
H-Index: 38
Ana Beloqui
H-Index: 17
An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers
2021/8/1
Oral delivery of biologics in inflammatory bowel disease treatment
2021/6/3
Ana Beloqui
H-Index: 17
Advances in lipid carriers for drug delivery to the gastrointestinal tract
2021/4/1
Yining Xu
H-Index: 8
Ana Beloqui
H-Index: 17
